ArticleMolecular therapy oncolytics2020

Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149.

Yuwen He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.